Owens & Minor Reports Second Quarter 2025 Financial Results
OMIRICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company’s Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company’s continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations. “We are in the final stages of our robust process for the divest
Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call
OMIRICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All inter
Baird Maintains Neutral on Owens & Minor, Raises Price Target to $10
OMIOwens & Minor Terminates Rotech Healthcare Acquisition, Redeems $1B Notes & Cancels Loan Commitments
OMIWhy Is Owens & Minor Stock Trading Lower On Thursday?
OMIOwens & Minor posts higher Q1 EPS, reaffirms 2025 guidance, and highlights strong Patient Direct growth while sales come in below estimates.
Owens & Minor Affirms FY2025 Adj EPS Guidance of $1.60-$1.85 vs $1.67 Est; Affirms FY2025 Sales Guidance of $10.85B-$11.15B vs $11.05B Est
OMIOwens & Minor Q1 Adj. EPS $0.23 Beats $0.20 Estimate, Sales $2.63B Miss $2.66B Estimate
OMIEarnings Outlook For Owens & Minor
OMICitigroup Maintains Buy on Owens & Minor, Lowers Price Target to $11
OMIOwens & Minor Reports Upsize And Pricing Of $1B Senior Secured Notes Offering
OMIOwens & Minor Launches Private Offering Of $600M Of Senior Secured Notes Due 2030
OMIDemystifying Owens & Minor: Insights From 5 Analyst Reviews
OMIJP Morgan Maintains Underweight on Owens & Minor, Lowers Price Target to $10
OMIBaird Maintains Neutral on Owens & Minor, Raises Price Target to $11
OMIHealthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares
OMIOwens & Minor beat Q4 EPS and revenue estimates, announced a $100M buyback, and provided 2025 guidance, projecting double-digit adjusted EBITDA growth.
Owens & Minor Says Active Discussions Well Underway Regarding Potential Sale of Products & Healthcare Services Segment
OMIOwens & Minor Expects 2025 Revenues Of $10.85B-$11.15B And Adjusted EPS Of $1.60-$1.85 Versus Consensus Of $10.97B And $1.79, Respectively
OMIOwens & Minor Authorizes Share Repurchase Program of Up to $100M
OMIOwens & Minor Q4 2024 Adj EPS $0.55 Beats $0.52 Estimate, Sales $2.70B Beat $2.69B Estimate
OMIBaird Maintains Neutral on Owens & Minor, Lowers Price Target to $10
OMIUBS Maintains Buy on Owens & Minor, Lowers Price Target to $13
OMIAnalyst Ratings For Owens & Minor
OMIUBS Maintains Buy on Owens & Minor, Lowers Price Target to $25
OMICitigroup Maintains Buy on Owens & Minor, Lowers Price Target to $18.5
OMIBarclays Maintains Equal-Weight on Owens & Minor, Lowers Price Target to $14
OMIBaird Maintains Neutral on Owens & Minor, Lowers Price Target to $14
OMIOwens & Minor Expects 2024 Adjusted EPS Of $1.45-$1.55 Compared To Prior Guidance Of $1.40-$1.70, Versus Consensus Of $1.60
OMIOwens & Minor Expects 2024 Revenue Of $10.6B-$10.8B Compared To Prior Guidance Of $10.5B-$10.9B And Consensus Of $10.713B
OMIOwens & Minor Q3 2024 Adj EPS $0.42 Beats $0.41 Estimate, Sales $2.72B Beat $2.68B Estimate
OMIHere's How Much $1000 Invested In Owens & Minor 5 Years Ago Would Be Worth Today
OMIRecap: Owens & Minor Q1 Earnings
OMIOwens & Minor (NYSE:OMI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Owens & Minor beat estimated earnings by 17.07%, reporting an EPS of $0.96 versus an estimate of $0.82.
Owens & Minor Q1 EPS $0.96 Beats $0.82 Estimate, Sales $2.41B Beat $2.31B Estimate; Raises Guidance
OMI